SOW
MIRM icon

State of Wyoming’s Mirum Pharmaceuticals MIRM Stock Holding History

State of Wyoming’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,687
Closed -$370K – 1947
2025
Q4 		$370K Buy
+4,687
New +$336K 0.04% 574
2025
Q3 		– Sell
-202
Closed -$10.3K – 1970
2025
Q2 		$10.3K Buy
+202
New +$8.99K ﹤0.01% 1761
2022
Q3 		– Sell
-773
Closed -$15K – 1769
2022
Q2 		$15K Buy
773
+555
+255% +$13.1K 0.01% 1541
2022
Q1 		$5K Buy
218
+183
+523% +$3.73K ﹤0.01% 1661
2021
Q4 		$1K Sell
35
-2
-5% -$31 ﹤0.01% 1814
2021
Q3 		$1K Sell
37
-18
-33% -$293 ﹤0.01% 1185
2021
Q2 		$1K Buy
+55
New +$986 ﹤0.01% 1138

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

State of Wyoming's MIRM Position: Q1 2026 in Review

State of Wyoming sold out of Mirum Pharmaceuticals (MIRM) in Q1 2026, closing a stake of 4,687 shares — an estimated $370K sold.

State of Wyoming first reported a position in MIRM in Q2 2021 and held it in 7 quarters. The position peaked at $370K in Q4 2025. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • State of Wyoming reported no remaining Mirum Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • State of Wyoming sold 4,687 Mirum Pharmaceuticals shares in Q1 2026, an estimated $370K.
  • State of Wyoming first reported a position in Mirum Pharmaceuticals in Q2 2021 and held it in 7 quarters.
  • State of Wyoming's Mirum Pharmaceuticals position peaked at $370K in Q4 2025.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.